In a large Scottish pedigree, a balanced translocation t(1;11)(q42.1;q14.3) segregates with major mental illness, including schizophrenia, bipolar disorder, and recurrent major depression. The translocation is predicted to result in the loss of the C-terminal region of the protein product of Disrupted In SChizophrenia 1 (DISC1), a gene located on 1q42.1. Since this initial discovery, DISC1 has been functionally implicated in several processes, including neurodevelopment. Based on the genetic and functional evidence that DISC1 may be associated with schizophrenia, we sequenced portions of DISC1 in 28 unrelated probands with schizophrenia and six unrelated probands with schizoaffective disorder, ascertained as part of a large sibpair study. We detected a 4 bp deletion at the extreme 3 0 end of exon 12 in a proband with schizophrenia. The mutation was also present in a sib with schizophrenia, a sib with schizoaffective disorder, and the unaffected father, while the mutation was not detected in 424 control individuals. The mutation is predicted to cause a frameshift and encode a truncated protein with nine abnormal C-terminal amino acids. The truncated transcript is detectable, but at a reduced level, in lymphoblastoid cell lines from three of four mutation carriers. These findings are consistent with the possibility that mutations in the DISC1 gene can increase the risk for schizophrenia and related disorders. Molecular Psychiatry (2005) 10, 758-764.
Schizophrenia is a devastating disease of major public health concern for which the available treatments are far from optimal. 1 Genetic factors are prominent in the etiology of schizophrenia, with heritability estimated at up to 80%, 2 but the apparent etiological complexity of most cases of schizophrenia has made it difficult to isolate specific genetic risk factors. Like the etiology, the pathogenesis of schizophrenia remains unknown. However, a substantial body of work suggests that schizophrenia may be a disorder of neurodevelopment, 3 implying that genes involved in the neurodevelopmental process may harbor mutations or polymorphisms that contribute to the risk of schizophrenia.
A balanced (1;11)(q42.1; q14.3) translocation has been described in a large Scottish pedigree that segregates with major psychiatric illnesses with LOD scores of 3.6 (schizophrenia only) to 7.1 (all major mental illness). 4 Family members who carry the translocation have a broad spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, and recurrent major depression. Although some translocation carriers are unaffected, all individuals with the aforementioned diagnoses carry the translocation. The affected family members have typical clinical syndromes, without prominent dysmorphia or mental retardation. 4 On 1q42.1, the translocation breakpoint segregating with major mental illness occurs in Disrupted In SChizophrenia 1 (DISC1). 5 The primary transcript of DISC1 consists of 13 exons, with a splice variant that excludes the distal 66 bp of exon 11. A short variant containing an alternative exon 9 is also expressed, and at least two shorter variants are also thought to exist. 6, 7 The translocation breakpoint falls in the intron between exons 8 and 9, and is predicted to result in a truncated protein, missing the final 257 residues of the long version of the protein. On the opposite strand, the translocation falls in the middle of DISC2, an apparently untranslated gene that has no known function. 5, 8 Other genetic studies have indicated that factors at the DISC1 locus may contribute to the risk of psychiatric disorders. Linkage 9,10 and association 11 of schizophrenia to 1q42 has been reported in Finnish populations, and linkage was also detected in a Taiwanese population. 12 Linkage to this region has also been reported in bipolar families. 13, 14 Haplotype analysis with markers in DISC1 suggests an association with bipolar disorder, schizoaffective disorder, and schizophrenia in a collection of American families. 15 The expression pattern and suggested function of DISC1 in neurodevelopment are consistent with a role for DISC1 mutations as risk factors for schizophrenia. DISC1 is expressed in multiple brain regions and in peripheral tissues. [16] [17] [18] [19] In the rat, DISC1 expression appears to peak in late embryonic life. 16 Similarly, in the mouse, DISC1 is upregulated in brain during the period of peak embryonic neurogenesis and at about the age of sexual maturation.
20 DISC1 levels increase during differentiation of PC12 cells and expression of a truncated version of DISC1 lacking the final 257 amino acids inhibits neurite outgrowth in PC12 cells. 16 Overexpression of normal DISC1 may increase neurite outgrowth. 21 DISC1 is localized to multiple subcellular domains, including the cytoskeleton, mitochondria, and nucleus. 7, 16, 22 The C-terminal region of DISC1 apparently lost in the Scottish pedigree following translocation, and especially the final coiled-coil region defined by amino acids 807-828, appears to be important for an interaction between DISC1 and Nudel. 23 This is of particular interest given the role of Nudel in neurodevelopment. [24] [25] [26] The genetic and functional evidence implicating DISC1 in schizophrenia and other psychiatric disorders is quite suggestive despite the fact that the translocation identified in the large Scottish pedigree has not been observed in other families. Further, as a translocation, it is difficult to exclude the possibility of effects at the other locus of translocation (11q14.3), although genes have not been identified at this location. 5, 8 It also remains possible that the translocation could influence other genes in the vicinity of DISC1 27 or that disruption of DISC2 could be of etiologic significance. Given these uncertainties, identification of additional DISC1 mutations that segregate with schizophrenia would substantially strengthen the case that DISC1 is an important factor in at least some cases of schizophrenia. We therefore sequenced DISC1 in probands with schizophrenia or schizoaffective disorder.
We describe an American family in which three siblings, two with schizophrenia and one with schizoaffective disorder, and their asymptomatic father, carry a frameshift mutation in the DISC1 gene. The 4 bp deletion at the 3 0 end of exon 12 was not observed in 424 controls or 99 other unrelated probands with schizophrenia or schizoaffective disorder. These findings provide additional evidence that DISC1 is a susceptibility gene for schizophrenia and schizoaffective disorder.
Materials and methods

Patient ascertainment
DNA was selected from 34 probands with schizophrenia or schizoaffective disorder and 66 additional probands were selected for subsequent mutation analysis from individuals ascertained as part of a large previously reported genetic study of schizophrenia in US pedigrees (see DeLisi et al 28 for details). All individuals gave written consent for participation in clinical evaluation and genetic studies as per the Institutional Review Board (IRB) at The State University of New York at Stony Brook. The protocol is currently approved by the IRBs of both Johns Hopkins University and New York University. In each case, consensus DSMIII-R diagnoses were made by two and, if necessary, three research psychiatrists using information derived from the Diagnostic Interview for Genetic Studies (DIGS), version 3.0. 29 Selection of 34 probands for DISC1 sequencing, 28 with schizophrenia and six with schizoaffective disorder, was based on the presence of another sibling with schizophrenia in 26 instances or schizoaffective disorder in the remaining eight cases. Additionally, 28 of the probands were chosen based on the presence of another first-degree family member with schizophrenia, schizoaffective disorder, bipolar disorder, schizotypal personality disorder or psychotic disorder not otherwise specified, while the remaining six were chosen based on the presence of an affected second-degree relative.
Control ascertainment
One population consisted of 68 individuals collected as controls for DNA deposit at the Coriell Institute. Four other control populations were ascertained from the Baltimore Huntington's Disease Clinic at Johns Hopkins, a clinic attracting a population from the Mid-Atlantic States, including 10% minorities. Protocols were approved by the Johns Hopkins IRB and all individuals provided informed consent. Samples were obtained from 30 unrelated spouses of individuals with Huntington's disease (HD), 183 spouses and other unaffected family members of HD patients from 61 different pedigrees, 60 individuals seeking HD presymptomatic testing who tested negative for the HD gene, and from 83 individuals with HD.
Genomic DNA amplification and sequencing Lymphoblastoid cells obtained from Coriell Cell Repositories were harvested and genomic DNA isolated according to the manufacturer's specifications (Gentra Systems). We have assessed DISC1 exon 12 and flanking regions by PCR using 100 ng DNA and an annealing temperature of 541C, with the forward primer 5 0 GGAGACACAGGCCCTAGCAC 3 0 and the reverse primer 5 0 ACTCCAGCCAAGGCATCAAA 3 0 . Sequencing was performed by the Johns Hopkins Genetics Core Facility in both directions by capillary electrophoresis (ABI 3730) with the aforementioned forward primer and an alternate reverse primer, 5 0 AGAGATCTGAGGTGCTCTGTGC 3 0 , to avoid repetitive sequence. Sequence was compared to GenBank reference sequence for identification of variants with the assistance of Sequencher version 4.1.4 (Gene Codes Corporation).
Mutation screening
All genomic DNA was extracted from lymphoblastoid cells or blood according to the manufacturer's specifications (Gentra Systems). The mutation was detected either by Hin4I digestion of the PCR product generated by the aforementioned primers, or with a TaqMan SNP Assay-By-Design (Applied Biosystems) in which the forward primer was 5 0 CACACAGC AATCCACAGTCATG 3 0 and the reverse primer was 5 
0 CCCTCC TGAGAGACTGA 3 0 were performed commercially using a standard protocol (Biotage).
Results
Analysis of exon 12 genomic sequence from 28 individuals with schizophrenia and six with schizoaffective disorder revealed a 4 bp deletion in one proband with schizophrenia ( Figure 1a) . The deletion results in the loss of one of two adjacent copies of the tetramer TCAT at the 3 0 end of exon 12, an exon expressed in both the DISC1 L and L V variants. 6 The second tetramer spans the exon-intron 12 splice junction, so that the AT of the tetramer falls within the intron (Figure 1b) . We obtained genomic DNA from all available family members of pedigree SB096 and performed a Hin4I RFLP assay. Results from the digest were subsequently confirmed by direct sequencing. In addition to the proband with schizophrenia, a sister with schizoaffective disorder (III:8) and a brother with schizophrenia (III:5) also carry the deletion (Figure 1c) . Unfortunately, the family is unavailable for any additional genotyping, examination or history beyond that detailed below and depicted in Figure 1c . The proband (III:7), age 34, has chronic undifferentiated schizophrenia. Medical records also suggest concomitant mild mental retardation. She experiences auditory and visual hallucinations, and has formal thought disorder, multiple delusions, and a flat and inappropriate affect. As a child, developmental milestones were delayed and she exhibited poor impulse control and aggressive behavior. She was first seen by a psychiatrist at age 6 and diagnosed with pervasive developmental disorder and childhood schizophrenia. Her first hospitalization was at age 16. She graduated from high school and has worked as a house cleaner. When last examined in 1993, she was in outpatient treatment, taking thiothixene, unemployed, and receiving Supplemental Security Income (SSI). She was living at home, with persistent auditory and visual hallucinations and thought disorder. Informants indicate that as of 2004 she continues to live with her parents.
No psychiatric diagnoses were observed in I:1, I:2, II:6 or II:7. Individuals II:1 and III:11 have schizophrenia, though information is limited. No information is available on III:3 or III:4, except that III:4 has two male children of ages 5 and 9. Both are in psychiatric care for autism or pervasive developmental disorder, and one is said to have Down's Syndrome.
The proband's brother III:5, who has chronic paranoid schizophrenia, is 46 years of age and single. He is a high-school graduate who works as a janitor and receives SSI. He has auditory and visual hallucinations, multiple delusions, formal thought disorder, but no depressive symptoms. The onset of psychosis was at age 16 and his first hospitalization was at age 23, with multiple hospitalizations since. At the time of assessment, in 1990 and 1992, he was taking fluphenazine and had no history of alcohol or drug abuse. He has one child (IV:4) who is said to have developmental problems, but details are uncertain. The proband's brother III:6 is 47 years of age with recurrent unipolar depression and panic attacks, married with two unaffected children of ages 2 and 6. He is a construction worker with some college education. There is no evidence of psychosis or axis II personality disorder. The proband's sister III:8 is 45 years of age, single, and was diagnosed with schizoaffective disorder, depressed type chronic, with an onset after high-school graduation at the age of 19. At this time, she stopped talking for six months and would only gesture for things she wanted. She was never hospitalized. She has some college education and worked part-time at unskilled jobs, but is now unable to work, lives with her parents, and receives SSI. Her disorder is marked by recurrent episodes of depression devoid of mania, along with paranoid and other delusions in the presence and absence of depression, as well as formal thought disorder and social withdrawal. She does not admit to auditory or visual hallucinations. The proband's sister III:9 with schizotypal personality disorder is 41 years of age, married with two unaffected adolescent children. She has no axis I disorder, but structured personality interview revealed mild paranoia (not psychotic), hypersensitivity, recurrent illusions, magical thinking, and some social isolation that met DSMIII-R criteria for schizotypal personality disorder. The proband's sister III:10 has had one episode of major depression now in remission, with no psychosis or axis II personality disorder. She is 40 years of age and has a master's degree and a professional administrative position.
RFLP and a TaqMan SNP Assay-By-Design were utilized for determining the presence of the 4 bp deletion in controls and additional schizophrenia probands. The mutation was not present in 66 other probands with schizophrenia or schizoaffective disorder or in genomic DNA isolated from 424 controls.
To ensure that the deletion does not affect splicing, RT-PCR products from four different sets of primers ( Figure 2a ) were cloned and 25 colonies were selected for sequencing. Of these 25 clones (six each from primer sets 1-3, seven from the fourth primer pair), eight products contained the deletion (Figure 2b) . None of the products revealed evidence of abnormal splicing. It therefore appears that the deletion results in a transcript missing 2420-2423 bp of NM_018662 with a subsequent shift in the reading frame and a premature stop codon at 2453 bp. The mutant transcript was expressed, though at reduced levels, in lymphoblastoid cell lines from three of the mutation carriers, but not in the sibling with schizoaffective disorder (III:8), as determined by RT-PCR followed by pyrosequencing. The predicted protein product has a truncated C-terminus, ending with nine abnormal amino acids beginning at residue 809 (Figure 2c ).
Discussion
The deletion identified in the DISC1 gene was present in two siblings with schizophrenia (III:5 and III:7), one with schizoaffective disorder (III:8) and their asymptomatic father (II:6). It was not found in the asymptomatic mother (II:7), two siblings with major depression (III:6 or III:10), or a sibling with schizotypal disorder (III:9). The mutation was not found in 424 controls or in 99 other probands with schizophrenia or schizoaffective disorder from multiplex families. Insufficient family members are available to definitively associate this mutation with schizophre-nia. However, one interpretation of the data, consistent with the family structure, is that the mutation is a major but incompletely penetrant risk factor for psychotic illness. The pedigree structure also suggests that other genetic risk factors for schizophrenia and affective disorder may be present.
Since the deletion identified here is one of two adjacent TCAT tetramers (Figure 1b ) that span the exon-intron 12 splice site, it is possible that the mutation could disrupt splicing. Our results suggest that the mutation does not lead to skipping of exon 12 or retention of intron 12 (Figure 2b ), though these experiments do not completely exclude the possibility that either a small fragment of intron 12 is retained in some transcripts, or that missplicing results in some transcripts that are rapidly degraded and hence undetectable. The available data, however, indicate that the mutation leads to a frameshift and the insertion of nine abnormal amino acids at the C-terminus (Figure 2c ).
RT-PCR followed by pyrosequencing revealed expression of the mutant transcript in the unaffected father (II:6), the sibling with schizophrenia (III:5) and the proband (III:7), but not in the sibling with schizoaffective disorder (III:8). Expression of the mutant transcript occurs at a lower level when compared to normal transcript in human lymphoblastoid cell lines, but caution is necessary in applying these results to the CNS, as it is likely that the level of expression of the mutant transcript will vary by cell type. It is also unknown whether mutant transcript yields a protein product in either the DISC1 frameshift mutant reported here or truncated DISC1 following translocation as reported in the Scottish pedigree. 23 Based on the presence of coiled-coil domains within DISC1 and the nearly 50 putative DISC1 interacting proteins thus far identified, DISC1 may act as a scaffolding protein. 16, 22, 30 The frameshift in DISC1 reported here eliminates a conserved coiledcoil domain that appears to be important for an interaction with Nudel. 23 Nudel contributes to the assembly of neurofilaments 26 and to the regulation of microtubular dynamics, 26 and it binds and regulates LIS1, a gene in which mutations are known to cause a severe failure of neuronal migration, resulting in the clinical entity lissencephaly. 31, 32 It is therefore possible that the DISC1 frameshift mutation may alter the interaction between DISC1 and Nudel, potentially disrupting neurodevelopmental processes mediated by Nudel. Elimination of the extreme C-terminal coiled-coil domain could also have a more pleiotropic effect on DISC1-mediated signaling, as this domain may be important for the interaction between DISC1 and other proteins. 30 If a relationship to schizophrenia is substantiated by additional functional and genetic evidence, the DISC1 mutation reported here would provide further evidence for a role of DISC1 in psychiatric disorders first suggested by the Scottish pedigree translocation. From a genetic perspective, this conclusion would Beginning at amino acid 807, truncated DISC1 protein predicted from transcripts containing the 4 bp exon 12 deletion is shown. The shaded box indicates the extreme Cterminal coiled coil domain (807-828) that is lost in the frameshift mutant. 23 For further details, please refer to Millar et al. 33 A portion of the Nudel-binding domain is also lost in the frameshift DISC1 mutant. 16, 22, 23 Two leucine zipper patterns (458-479 and 607-628 demarcated as LZ), a glutamine-rich region (460-517, Q), and a bipartite nuclear localization signal (331-348, NLS) were identified using MotifScan (http://myhits.isb-sib.ch/cgi-bin/motif_scan). The arrow indicates the translocation breakpoint identified in the Scottish pedigree. 5 imply that other mutations in genes in DISC1-related pathways might also substantially increase the risk of schizophrenia and other forms of mental illness. A second implication is that common polymorphisms in this group of genes might have smaller but more frequent effects on the risk of disease, which could account for the multiple intriguing but not necessarily significant linkage and association findings to the 1q42 locus and to loci that include genes associated with DISC1. In addition, an association between DISC1 and schizophrenia would strongly support the developmental hypothesis of schizophrenia, and would serve to focus neuropathological and pathophysiological investigations on those aspects of neurodevelopment regulated by the DISC1-associated pathways.
